RCM
ZBH icon

Riverhead Capital Management’s Zimmer Biomet ZBH Stock Holding History

Riverhead Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$855K Sell
6,413
-721
-10% -$93.1K 0.03% 530
2019
Q2 		$816K Sell
7,134
-2,781
-28% -$326K 0.03% 554
2019
Q1 		$1.23M Sell
9,915
-206
-2% -$23.4K 0.05% 429
2018
Q4 		$1.02M Sell
10,121
-1,110
-10% -$125K 0.05% 442
2018
Q3 		$1.43M Sell
11,231
-422
-4% -$50.2K 0.05% 390
2018
Q2 		$1.26M Buy
11,653
+904
+8% +$98.4K 0.05% 406
2018
Q1 		$1.14M Buy
10,749
+195
+2% +$22.6K 0.05% 398
2017
Q4 		$1.24M Buy
10,554
+639
+6% +$72.3K 0.05% 376
2017
Q3 		$1.13M Buy
9,915
+155
+2% +$17.9K 0.05% 375
2017
Q2 		$1.22M Sell
9,760
-28
-0.3% -$3.32K 0.06% 342
2017
Q1 		$1.16M Buy
9,788
+1,109
+13% +$126K 0.06% 336
2016
Q4 		$870K Buy
8,679
+103
+1% +$11K 0.05% 366
2016
Q3 		$1.08M Buy
8,576
+5,800
+209% +$717K 0.07% 314
2016
Q2 		$74K Sell
2,776
-33,542
-92% -$3.8M ﹤0.01% 1251
2016
Q1 		$3.76M Buy
36,318
+988
+3% +$95.6K 0.05% 388
2015
Q4 		$3.52M Sell
35,330
-13,091
-27% -$1.28M 0.05% 402
2015
Q3 		$4.42M Buy
48,421
+807
+2% +$80.9K 0.07% 323
2015
Q2 		$5.05M Buy
47,614
+1,232
+3% +$136K 0.08% 317
2015
Q1 		$5.29M Sell
46,382
-421
-0.9% -$48K 0.08% 296
2014
Q4 		$5.15M Buy
46,803
+3,642
+8% +$384K 0.08% 292
2014
Q3 		$4.21M Buy
43,161
+4,109
+11% +$404K 0.07% 311
2014
Q2 		$3.94M Buy
39,052
+2,547
+7% +$249K 0.07% 313
2014
Q1 		$3.35M Buy
36,505
+542
+2% +$50K 0.07% 307
2013
Q4 		$3.25M Sell
35,963
-21,239
-37% -$1.84M 0.09% 282
2013
Q3 		$4.56M Buy
57,202
+7,210
+14% +$568K 0.15% 185
2013
Q2 		$3.64M Buy
+49,992
New +$3.74M 0.12% 209

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverhead Capital Management's ZBH Position: Q3 2019 in Review

Riverhead Capital Management reduced its Zimmer Biomet (ZBH) stake by 10% in Q3 2019, selling an estimated $93.1K and leaving 6,413 shares worth $855K. The position accounts for 0.03% of the portfolio, ranked #530.

Riverhead Capital Management first reported a position in ZBH in Q2 2013 and has held it in 26 quarters since. The position peaked at $5.29M in Q1 2015. 897 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

  • Riverhead Capital Management held 6,413 shares of Zimmer Biomet worth $855K as of Q3 2019.
  • Riverhead Capital Management sold 721 Zimmer Biomet shares in Q3 2019, an estimated $93.1K.
  • Zimmer Biomet made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #530 holding.
  • Riverhead Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Zimmer Biomet position peaked at $5.29M in Q1 2015.
  • 897 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.